Teva Pharmaceutical Indus
(NYSE:TEVA)
$7.94
0.11[1.40%]
At close: Jun 29
$7.99
0.0500[0.63%]
After Hours: 7:12PM EDT
Day High/Low7.78 - 7.98
52 Week High/Low7.23 - 10.5
Open / Close7.89 / 7.95
Float / Outstanding- / 1.1B
Vol / Avg.9.7M / 10.1M
Mkt Cap8.8B
P/E-
50d Avg. Price8.45
Div / Yield-
Payout Ratio-
EPS-0.86
Total Float1.1B

Teva Pharmaceutical Indus (NYSE:TEVA), Quotes and News Summary

Teva Pharmaceutical Indus (NYSE: TEVA)

Day High/Low7.78 - 7.98
52 Week High/Low7.23 - 10.5
Open / Close7.89 / 7.95
Float / Outstanding- / 1.1B
Vol / Avg.9.7M / 10.1M
Mkt Cap8.8B
P/E-
50d Avg. Price8.45
Div / Yield-
Payout Ratio-
EPS-0.86
Total Float1.1B
Benzinga - May 3, 2022, 7:03AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Based in Israel, Teva is one of the world's largest generic drug manufacturers, with over 3,500 products marketed in over 60 countries. While a majority of its revenue is attributed to prescription generic drugs, Teva develops and markets its own branded specialty and biopharmaceutical products, primarily in the U.S. and in Europe. The company's branded portfolio generates one fifth of total revenue and consists of patented therapies targeting central nervous system conditions (Austedo, Ajovy, Copaxone), oncology (Bendeka/Treanda), and respiratory conditions (ProAir, Qvar). While global competition has facilitated the commodification of small-molecule generic drugs, Teva's portfolio rationalization has resulted in less overall price erosion versus peers.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-27
REV
Q1 2022Est.ActualSurprise
EPS0.5500.550 0.0000
REV3.750B3.661B-89.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Teva Pharmaceutical Indus Questions & Answers

Q
How do I buy Teva Pharmaceutical Indus (TEVA) stock?
A

You can purchase shares of Teva Pharmaceutical Indus (NYSE: TEVA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Teva Pharmaceutical Indus's (TEVA) competitors?
Q
What is the target price for Teva Pharmaceutical Indus (TEVA) stock?
A

The latest price target for Teva Pharmaceutical Indus (NYSE: TEVA) was reported by UBS on Tuesday, June 14, 2022. The analyst firm set a price target for 10.00 expecting TEVA to rise to within 12 months (a possible 25.94% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Teva Pharmaceutical Indus (TEVA)?
A

The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $7.94 last updated June 29, 2022, 7:59 PM UTC.

Q
Does Teva Pharmaceutical Indus (TEVA) pay a dividend?
A

A quarterly cash dividend of $0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2017 to stockholders of record on November 28, 2017.

Q
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
A

Teva Pharmaceutical Indus’s Q2 earnings are confirmed for Wednesday, July 27, 2022.

Q
Is Teva Pharmaceutical Indus (TEVA) going to split?
A

There is no upcoming split for Teva Pharmaceutical Indus.

Q
What sector and industry does Teva Pharmaceutical Indus (TEVA) operate in?
A

Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.